Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2

Yuan Xiao Zhu, Hongwei Yin, Laura A. Bruins, Chang-Xin Shi, Patrick Jedlowski, Meraj Aziz, Chris Sereduk, Klaus Martin Kortuem, Jessica E. Schmidt, Mia Champion, Esteban Braggio, A. Keith Stewart

Blood (2015) 125 (3): 483–491.

https://doi.org/10.1182/blood-2014-05-577130

Published: 2015

Includes: Supplemental data

Journal Articles

Pharmacological Validation Of Potentiating Targets From SAHA RNA-Interference Modifier Screens In Acute Myeloid Leukemia

James M Bogenberger, PhD, James Rudd, Donald Chow, Michelle Kassner, Veena Fauble, MD, Ruben A. Mesa, MD, Hongwei Yin, PHD, Casey Greene, PhD, Raoul Tibes, MD, PhD

Blood (2013) 122 (21): 3832.

https://doi.org/10.1182/blood.V122.21.3832.3832

Published: 2013

Journal Articles

RNAi Screening of the Human Kinome Identifies Inhibition of WEE1 Kinase As Potent and Universal Sensitizing Target to Cytarabine in Leukemias

Raoul Tibes, MD, PhD, Leena Chaudhuri, PhD, James M Bogenberger, PhD, Tanner R Hagelstrom, PhD, MBA, Amanda McNally, MS, Donald Chow, Megan E Buechel, MS, Irma Gonzales, Esteban Braggio, PhD, Hongwei Yin, PHD, Shilpi Arora, PhD, David Azorsa, PhD, Craig B. Reeder, MD, Pierre Noel, MD, James L. Slack, MD, Ruben A. Mesa, MD, Tim Demuth, MD, PhD

Blood (2011) 118 (21): 229.

https://doi.org/10.1182/blood.V118.21.229.229

Published: 2011

Journal Articles

Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6

Rodger E. Tiedemann, Yuan Xiao Zhu, Jessica Schmidt, Hongwei Yin, Chang-Xin Shi, Qiang Que, Gargi Basu, David Azorsa, Louise M. Perkins, Esteban Braggio, Rafael Fonseca, P. Leif Bergsagel, Spyro Mousses, A. Keith Stewart

Blood (2010) 115 (8): 1594–1604.

https://doi.org/10.1182/blood-2009-09-243980

Published: 2010

Includes: Supplemental data

Journal Articles

Kinome-Wide RNAi Studies in Human Multiple Myeloma Identify a Lymphoid Restricted Kinase GRK6 as a Selectively Vulnerable Target That Regulates STAT3/MCL1.

Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Yuan Xiao Zhu, Jessica Schmidt, BS, Hongwei Yin, PhD, Quick Que, PhD, David Azorsa, PhD, Louise M. Perkins, PhD, Esteban Braggio, PhD, Craig B. Reeder, MD, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Spyro Mousses, PhD, A. Keith Stewart, MD

Blood (2009) 114 (22): 601.

https://doi.org/10.1182/blood.V114.22.601.601

Published: 2009

Journal Articles

Achilles Heel Molecular Vulnerabilities in Multiple Myeloma Identified From Genome-Scale RNA Interference Screening.

Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Yuan Xiao Zhu, Jessica Schmidt, BS, Chang-Xin Shi, Hongwei Yin, PhD, Spyro Mousses, PhD, A. Keith Stewart, MD

Blood (2009) 114 (22): 2801.

https://doi.org/10.1182/blood.V114.22.2801.2801

Published: 2009

NARROW

RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2

Pharmacological Validation Of Potentiating Targets From SAHA RNA-Interference Modifier Screens In Acute Myeloid Leukemia

RNAi Screening of the Human Kinome Identifies Inhibition of WEE1 Kinase As Potent and Universal Sensitizing Target to Cytarabine in Leukemias

Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6

Kinome-Wide RNAi Studies in Human Multiple Myeloma Identify a Lymphoid Restricted Kinase GRK6 as a Selectively Vulnerable Target That Regulates STAT3/MCL1.

Achilles Heel Molecular Vulnerabilities in Multiple Myeloma Identified From Genome-Scale RNA Interference Screening.

Email alerts

ASH Publications

American Society of Hematology

RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2

Pharmacological Validation Of Potentiating Targets From SAHA RNA-Interference Modifier Screens In Acute Myeloid Leukemia

RNAi Screening of the Human Kinome Identifies Inhibition of WEE1 Kinase As Potent and Universal Sensitizing Target to Cytarabine in Leukemias

Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6

Kinome-Wide RNAi Studies in Human Multiple Myeloma Identify a Lymphoid Restricted Kinase GRK6 as a Selectively Vulnerable Target That Regulates STAT3/MCL1.

Achilles Heel Molecular Vulnerabilities in Multiple Myeloma Identified From Genome-Scale RNA Interference Screening.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only